Siemens reviewing Healthineers majority stake: CFO tells Handelsblatt
Siemens AG is evaluating its majority stake in Siemens Healthineers, its medical technology subsidiary, the German technology group's Chief Financial Officer Ralf Thomas told the Handelsblatt newspaper.
"We are evaluating the economic opportunities for Siemens AG in the healthcare sector. We will then derive from this how instrumental Healthineers is as an investment. And then we will draw a conclusion from that," Thomas said. The findings of this review are expected to be unveiled at a capital markets day at the end of 2025.
The synergies with the manufacturer of MRI machines and laboratory systems are not great enough to justify a capital commitment of 45 billion euros ($46.91 billion), Thomas told Handelsblatt, referring to how much Siemens' 75% equity stake is worth.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.